Interleukin-24 (IL-24), a member of the IL-10 cytokine family whose physiological function remains largely unknown, has been shown to induce apoptosis when expressed in an adenoviral background. It is yet little understood, why IL-24 alone induced apoptosis only in a limited number of tumor cell lines. Analyzing an influenza A virus vector expressing IL-24 for its oncolytic potential revealed enhanced pro-apoptotic activity of the chimeric virus compared with virus or IL-24 alone. Interestingly, IL-24-mediated enhancement of influenza-A-induced apoptosis did not require viral replication but critically depended on toll-like receptor 3 (TLR3) and caspase-8. Immunoprecipitation of TLR3 showed that infection by influenza A virus induced formation of a TLR3-associated signaling complex containing TRIF, RIP1, FADD, cFLIP and pro-caspase-8. Co-administration of IL-24 decreased the presence of cFLIP in the TLR3-associated complex, converting it into an atypical, TLR3-associated death-inducing signaling complex (TLR3 DISC) that induced apoptosis by enabling caspase-8 activation at this complex. The sensitizing effect of IL-24 on TLR3-induced apoptosis, mediated by influenza A virus or the TLR3-specific agonist poly(I:C), was also evident on tumor spheroids. In conclusion, rather than acting as an apoptosis inducer itself, IL-24 sensitizes cancer cells to TLR-mediated apoptosis by enabling the formation of an atypical DISC which, in the case of influenza A virus or poly(I:C), is associated with TLR3. Interleukin-24 (IL-24) was identified to be upregulated in differentiated and non-proliferating melanoma cells. 1 Shortly after its discovery, IL-24 attracted interest as a therapeutic agent as adenoviral overexpression of IL-24 (Ad-IL-24) induced apoptosis in cancer cells. 2 Subsequently, the therapeutic potential of Ad-IL-24 has been confirmed in a number of different solid cancer models, [3] [4] [5] which led to further evaluation of this immunotherapy in clinical trials. Analysis of the mechanism of Ad-IL-24-induced apoptosis revealed the activation of multiple pro-apoptotic events including phosphorylation of PKR and eIF2a, cleavage of caspase-8 and caspase-3, 6 activation of p38 MAPK 7 and ERK, 8 downregulation of Mcl-1 9 and the induction of pro-apoptotic Bcl-2 family members 10 (reviewed in 11, 12) . In addition, IL-24 expressed by adeno-associated viruses was shown to reduce leukemia outgrowth of an MLL/AF4-positive ALL. 13 There is, however, conflicting data concerning the apoptosis-inducing properties of IL-24 expressed and delivered by sources other than viral overexpression. Several groups reported that IL-24 secreted from transformed embryonic kidney cells (HEK293) or bacterial GST-IL-24 fusion protein induced apoptosis in a variety of cancer cells. [14] [15] [16] [17] [18] Other groups, however, could not observe growth reduction of cancer cells treated with IL-24. 19, 20 We therefore reasoned that a currently unknown second stimulus might be necessary to promote the apoptotic activity of IL-24 or that addition of IL-24 turns a stimulus that usually does not induce cell death into an apoptosis-inducing one.
Various toll-like receptors (TLRs) have been described to be capable of inducing apoptosis under certain conditions. [21] [22] [23] TLRs belong to the family of pattern recognition receptors and have a major role in host defense against invading pathogens. Their stimulation mainly leads to activation of the innate immune system but can also result in cell death induction.
Especially stimulation of TLR3 has been described to induce apoptosis when protein biosynthesis is concomitantly blocked. 23 Stimulation of TLR3 by its ligand, double-stranded RNA, has recently been shown to result in the formation of a TLR3-associated atypical death complex consisting of its adapter molecule TRIF, as well as RIP1, FADD, procaspase-8 and cFLIP. 23, 24 Lack of the short-lived cFLIP in this complex leads to the activation of caspase-8 and, subsequently, caspase-3-mediated apoptotic cell death. Recently, Feoktistova et al. 25 provided evidence that absence of cellular inhibitor of apoptosis proteins (cIAPs) sensitizes cells to a TLR3-mediated cell death. Whether TLR3 stimulation, in the absence of cIAPs, leads to apoptosis or necroptosis is differentially regulated by the two cFLIP isoforms, cFLIP long and short (cFLIP L and cFLIP S ), and depends on the presence or absence of RIP3.
In previous studies, we developed the first prototype of an oncolytic influenza A virus 26 based on deletions in the viral type I interferon antagonist NS1 (delNS1). 27, 28 We recently generated delNS1-based viral vectors that induce stable expression of secreted versions of foreign proteins, including IL-24 (delNS1/IL-24). 29 Analysis of the cytotoxic properties of delNS1 and delNS1/IL-24 on tumor cells revealed that infection by the IL-24-encoding virus was strikingly more active in killing tumor cells than infection by delNS1. The cell death induced by delNS1/IL-24 was exclusively apoptotic, depended on virus-induced stimulation of TLR3 and activation of caspase-8 but did not require productive infection. Our results identify IL-24 as a factor that promotes tumor cell death by enabling TLR3-induced apoptosis.
Results
Characterization of viral growth and transgene expression of delNS1/IL-24. We first compared the replication properties of influenza A wild-type (wt) virus, empty vector delNS1 and delNS1/IL-24. 29 Similar to delNS1, delNS1/IL-24 retained the ability to grow on both, a prostateand a melanoma-derived tumor cell line (DU145 and SK-Mel28, respectively). As expected, growth of the viruses with the deletion in NS1 was reduced as compared with wt virus. DelNS1 also grew in the producer cell line VERO (data not shown). Virally expressed IL-24 was secreted at up to 6 ng/ml into the supernatants of the cell lines infected by delNS1/IL-24 (Table1).
IL-24 leads to enhanced influenza A virus-induced cell death. We next analyzed whether expression of IL-24 by delNS1/IL-24 enhances cell death induction in DU145-( Figure 1a ) and SK-Mel28 cells (Supplementary Figure  S1a) in comparison to delNS1. In line with previous reports, 30 we found that delNS1 induced higher levels of cell death in DU145 cells than wt virus (21.0 versus 12.6%, respectively). Importantly, infection of DU145 cells with delNS1/IL-24 resulted in significantly more cell death (up to 36.4%, P ¼ 0.03) than infection with delNS1 or wt virus. Interestingly, the combination of recombinant human (rh) IL-24 with either wt virus or delNS1 induced late apoptotic/necrotic cells up to 35.8% (P ¼ 0.001) and 42.9% (P ¼ 0.01), respectively. This indicates that neither intracellular synthesis nor autocrine action of IL-24 is required for its cell death-promoting effect. Of note, adding only rhIL-24 to either cell line did not induce cell death. Similar results were obtained for SK-Mel28 cells (Supplementary Figure S1a) . We therefore conclude that presence of IL-24 leads to enhanced influenza A virusinduced cell death.
DelNS1/IL-24-induced cell death in tumor cells is mediated by structural components of the virus and not due to virus-mediated cytokine induction. It is known that structural parts of influenza A virus particles, such as viral RNA, or the interaction of the viral entry protein with the cellular receptor can activate TLR3 31, 32 and TLR7
33
(for review see 34 ). To elucidate whether a structural component of the virus is sufficient to induce cell death in the presence of IL-24 or whether viral replication is required for cell death induction, we used heat-inactivated (hi)-delNS1 that retains the capacity to bind to the viral receptor but is incapable of replicating in the cell. Co-stimulation of DU145 ( Figure 1a ) and SK-Mel28 (Supplementary Figure S1a) cells with rhIL-24 and hi-delNS1 significantly increased the amount of early and late apoptotic/necrotic cells (for DU145 cells up to 41%; P ¼ 0.002). Thus, presence of the virus particle itself appears to be sufficient to enable induction of tumor cell death in the presence of rhIL-24. As 100 ng/ml was the minimal dose of rhIL-24 capable of promoting cell death in combination with hi-delNS1 (Supplementary Figure S2a) , this concentration was used for further experiments.
As virus-induced cytokines like type I IFN, type II IFN or TNF could be responsible for the virus-mediated component of IL-24/hi-delNS1-induced cell death, we next determined whether inhibition of these cytokines interfered with cell death induction by hi-delNS1 and rhIL-24. This was, however, not the case, suggesting a minor role, if any, for these cytokines in IL-24/hi-delNS1-mediated cell death (Supplementary Figure S2b) . This is further corroborated by the fact that co-stimulation by type I or II IFNs or TNF, each at 100 ng/ml, together with rhIL-24 did not promote induction of cell death (data not shown).
IL-24/influenza A virus induces apoptosis, not necroptosis. We next determined the type of cell death induced by influenza A virus in combination with IL-24. To differentiate between apoptosis and regulated necrosis, also referred to as necroptosis, we tested how the apoptosispreventing caspase inhibitor zVAD-fmk (zVAD) and the To further substantiate our findings on the induction of apoptosis, rather than necroptosis, by the combination of influenza A virus and IL-24, we analyzed the effect of zVAD and Nec-1 on caspase-3 activation in DU145-( Figure 1c ) and SK-Mel28 cells (Supplementary Figure  S1c) . Addition of zVAD blocked the cleavage of caspase-3 after infection with delNS1/IL-24 or the combinatorial stimulation by rhIL-24 and wt virus, delNS1 or hi-delNS1. Corresponding to the AnnexinV/PI data, no decrease in the levels of cleaved caspase-3 was found in any of the cases when Nec-1 was added.
We reasoned that the lack of necroptosis induction might be due to the absence of RIP3. Indeed, neither DU145 nor SKMel28 cells express RIP3 (Figure 6a and Supplementary Figure S7a) . Thus, the combination of IL-24 and influenza A virus induces apoptosis, not necroptosis in the cellular systems employed in this study.
Molecular changes induced by influenza A virus and IL-24.
To better understand the mechanism of apoptosis induction by influenza A virus/IL-24, we next investigated how this treatment affected the pro-apoptotic signaling cascades that had previously been described to be induced by IL-24-expressing chimeric adenovirus, namely phosphorylation of PKR and eIF2a, cleavage of caspase-8 and caspase-3, activation of p38 MAPK and ERK and downregulation of Mcl-1 ( Figure 2 and Supplementary Figure S3 ). All influenza A virus/IL-24 combinations that induced apoptosis also led to the phosphorylation of PKR and eIF2a. However, the observation that empty delNS1 virus stimulation alone also induced PKR activation, but was not associated with high levels of apoptosis, suggests that PKR and eIF2a activation alone were not sufficient to enhance apoptosis. Induction of apoptosis and caspase-3 activation in influenza A virus/IL-24-stimulated cells also correlated with phosphorylation of p38 MAPK. ERK activation was seen in all virus/IL-24 combinations except when rhIL-24 was added to wild-type virus. Furthermore, apoptosis induction and caspase activation were associated with downregulation of Mcl-1 (Figure 2a) , indicating that this factor might be important for apoptosis prevention in this cellular setting. Interestingly, rhIL-24 alone neither induced activation or expression of any of the above-mentioned pro-apoptotic molecules nor downregulation of anti-apoptotic Mcl-1. Of note, neither GADD nor total levels of Bak, Bax, Bcl-xL or Bcl-2 (data not shown) were significantly modulated during combinatorial stimulation by influenza A virus and IL-24. We neither observed an expression or induction of JNK or TRAF6 in virus/IL-24-stimulated cells (data not shown).
IL-24 promotes apoptosis by enabling TLR3-mediated activation of caspase-8. We next aimed to further investigate whether TLR stimulation was indeed responsible for influenza A virus/IL-24-induced apoptosis in DU145-( Figure 3 ) and SK-Mel28 cells (Supplementary Figure S4) . Therefore, we tested agonists for TLR3 (poly(I:C)) and TLR7 (CL-097) in combination with IL-24 as influenza A virus particles have been described to be able to bind to these two TLRs. [31] [32] [33] We also applied LPS because TLR4 had previously been described to be capable of inducing apoptosis. 21 Single treatment of DU145 cells with any of the three agonists did not increase levels of cell death. In contrast, combined stimulation by rhIL-24 with poly(I:C), but not with LPS or CL-097, significantly increased apoptosis and enhanced caspase-3 cleavage in both cell lines. Hence, To further investigate the role of IL-24 stimulation in TLR3-mediated apoptosis, we employed two different approaches to inhibit TLR3 signaling. Firstly, we used a pharmacological inhibitor of TLR signaling, resveratrol (3, 4 0 , 5-trihydroxytrans-stilbene), a phenolic phytoalexin found in grape skin and other plants. Resveratrol suppresses MyD88-independent signaling pathways engaged by TLR3 and TLR4. 37 At 50 mM, resveratrol decreased the amount of early and late apoptotic cells from 40.8% ± 0.8 to 22% ± 1.4 in delNS1/IL-24 virusinfected DU145 cells (P ¼ 0.05) (Figure 4) . A similar decrease was found when resveratrol was added to samples stimulated with rhIL-24 in combination with delNS1, hi-delNS1 or poly(I:C). By contrast, no decrease in apoptosis was observed following infection with delNS1 or hi-delNS1, or by treatment with poly(I:C) alone in the presence of resveratrol. Similar observations were made in SK-Mel28 cells (Supplementary Figure S5) .
Secondly, we suppressed the expression of TLR3 using RNA interference (RNAi). Short-interfering RNAs (siRNAs) directed against TLR3 reduced the expression of this receptor by 480% (Figure 5a and Supplementary Figure S6a ) and prevented caspase-3 cleavage induced by infection with delNS1/IL-24. In cells stimulated with rhIL-24 in combination with delNS1, hi-delNS1 or poly(I:C) cleavage of caspase-3 was also prevented by TLR3 knockdown (Figure 5b and Supplementary Figure S6b) .
To test the contribution of caspase-8 to apoptosis induction by TLR3 and IL-24-co-stimulation, we next suppressed the expression of this caspase by siRNA (Figure 5c and Supplementary Figure S6c) . Knockdown of caspase-8 abrogated caspase-3 activation (Figure 5d and Supplementary Figure S6d ). This result indicates that caspase-8 activation is not collateral to, but is required for, TLR3/IL-24-mediated apoptosis. Thus, IL-24 enables TLR3 to induce apoptosis in a caspase-8-dependent manner.
IL-24 converts the TLR3-associated signaling complex, activated by influenza A virus-mediated stimulation, into an apoptosis-inducing platform. Influenza A virus is capable of activating TLR3 signaling and TLR3 can mediate apoptosis under certain circumstances.
23,24 Therefore, we next determined whether treatment of tumor cells with different combinations of virus and IL-24 modulates expression of molecules involved in the formation and signaling of the recently described TLR3-associated signaling complex 24, 25 in a manner that an atypical TLR3-associated death-inducing signaling complex (TLR3 DISC) may form. We first analyzed overall expression of TRIF, FADD, RIP1, RIP3, cFLIP and cIAP1 in cell lysates. Apoptosis induced by infection of DU145 with delNS1/IL-24, or combinatorial treatment of cells with either wt virus, delNS1 or hi-delNS1 and rhIL-24 (as determined in Figure 1a ) correlated with activation of caspase-8 and caspase-3 and decreased expression of cIAPs, cFLIP L and cFLIP S (Figure 6a) . Expression of TRIF, FADD, RIP1 or other molecules known to form part of the TLR3-associated signaling complex was not significantly altered. By performing TLR3 pull-downs and subsequent analysis by western blotting, we next determined Figure S8) . By contrast, the empty delNS1 only inhibited further outgrowth of spheroids. Treatment with rhIL-24 alone, however, had no effect. The apparent growth reduction of spheroids by delNS1/IL-24 was almost completely inhibited by the caspase inhibitor zVAD, but not by the necroptosis inhibitor Nec-1. We next tested the effect of poly(I:C) and rhIL-24 in those three-dimensional cell cultures. The combination of LPS and rhIL-24 was used as a control to rule out unspecific immune-mediated effects. Inhibition of growth was only observed for spheroids treated with the combination of poly(I:C) and rhIL-24 ( Figure 7c and Supplementary Figure 8c) . Hence, in the presence of IL-24, tumor cells in spheroid cultures are as susceptible to apoptosis induction by stimulation of TLR3 as in twodimensional culture.
Discussion
Although its physiological role remains to be determined, the pro-apoptotic activity of IL-24 on tumor cells has recently gained attention. 7, [38] [39] [40] [41] [42] [43] Here, we demonstrate that IL-24 expressed by influenza A virus acts as a sensitizer to influenza A virus-mediated apoptosis, rather than as a celldeath inducer itself. Interestingly, influenza A virus-induced cell death in the presence of IL-24 is mediated by TLR3 and the formation of an atypical TLR3-associated DISC at which caspase-8 is activated, resulted in subsequent activation of caspase-3 and, hence, induction of apoptosis. Therefore, our findings indicate that (i) an appropriate additional stimulus is required for IL-24 to promote apoptosis and (ii) that armed oncolytic influenza A viruses can provide such a second signal by activating TLR3 in a pro-apoptotic manner.
Hence, the observed differences in reactivity of tumor cell lines following stimulation with recombinant IL-24 alone might very well be due to the presence or absence of a second signal and activation of the respective downstream signaling pathway. The fact that adenovirus-or adeno-associated virus-expressed IL-24 always induced cell death suggests that adenovirus inherently provides an appropriate second signal, similar to our observations regarding influenza A virus. As adenoviruses and adeno-associated viruses are known to primarily stimulate TLR2 and TLR9, [44] [45] [46] induction of IL-24-enabled TLR-mediated apoptosis is possibly not restricted to the stimulation of TLR3. It will be interesting to determine which other pattern recognition stimuli, in addition to TLR3, induce apoptosis when combined with IL-24.
Of note, we find the cell death induced by influenza A virus/ IL-24 to be exclusively apoptotic although Feoktistova et al. 25 recently described that TLR3-stimulation can also result in the induction of necroptosis. This is likely a consequence of Figure 6 Effect of IL-24 and/or virus stimulation on proteins involved in apoptosis induction and on TLR3 DISC formation in DU145 cells. (a) Cells were infected with wt virus, delNS1, delNS1/IL-24, hi-delNS1 (moi ¼ 1) or in combination with rhIL-24 (100 ng/ml) for 24 h as indicated on the top. Protein expression level of cIAP1, TRIF, FADD, RIP1, RIP3, cFLIP L and cFLIP S was determined by western blot analysis. One representative western blot out of three independent experiments is shown. (b) Cells were left untreated or treated with rhIL-24 alone, infected with hidelNS1 (moi ¼ 1) alone or in combination with rhIL-24 (100 ng/ml) for 24 h. TLR3 was immunoprecipitated and subjected to western blot analysis for the proteins indicated. One representative experiment out of three independent experiments is shown IL-24 sensitizes to TLR3-mediated apoptosis R Weiss et al absence of RIP3 from the cell lines used in this study. Hence, although the death induced by influenza A virus/IL-24 in this study is apoptotic, it cannot be excluded that in other cellular settings in which the necroptosis pathway is operative, this combination may also be capable of inducing necroptosis. Previously, it has been shown that adenovirus expressing IL-24 induces multiple pro-apoptotic events including phosphorylation of PKR and eIF2a, cleavage of caspase-8 and -3, activation of p38 MAPK and ERK, downregulation of Mcl-1 and the induction of pro-apoptotic Bcl-2 family members. [6] [7] [8] [9] [10] Although IL-24-expressing influenza A virus induced similar changes except for the induction of pro-apoptotic Bcl-2 family members, none of the observed changes could be attributed to the IL-24-mediated sensitization to TLR3-induced apoptosis. Yet, in addition to the previously reported effects, we also observed downregulation of cIAP1 and both isoforms of cFLIP by the combination of influenza A virus and IL-24. That cFLIP and cIAP1 have a major role in regulation of cell death induced by TLRs in general and TLR3 in particular is evidenced by a number of publications: (i) cIAPs sensitizes cells to TLR3-induced cell death via formation of a molecular platform whose signaling output in respect to apoptosis and necroptosis is differentially regulated by cFLIP isoforms; 25 (ii) Estornes et al. 24 recently showed that cFLIP forms part of an atypical death complex associating TLR3 to caspase-8; (iii) cFLIP L inhibits TLR3-induced apoptosis in dendritic cells; 47 (iv) cFLIP has been shown to be relevant for apoptosis mediated by the activation of TLR3 and TLR4 when protein synthesis is blocked by cycloheximide (CHX). 23, 48 In conclusion, we show that IL-24 acts as a sensitizer to TLR3-mediated cell death, rather than a cell-death inducer itself. The synergistic capacity of IL-24 and TLR3 agonists to induce tumor cell death might lead to novel therapeutic options in cancer. Specifically, oncolytic RNA viruses appear suitable for the expression of IL-24 in this context. Our findings could also hint at the physiological function of IL-24, as this cytokine may contribute to the elimination of infected or otherwise activated, including transformed cells by sensitizing to apoptosis during the course of an inflammation. 49 Materials and methods Cell lines, influenza viruses and reagents. The human prostate cancer cell line DU145 was purchased from ATCC (ACC 261). Cells were maintained in a MEM medium (PAA, Pasching, Austria) supplemented with 10% heat-inactivated FCS. The human melanoma cell line SK-Mel28 was purchased from ATCC (HTB-72) and was grown in DMEM/F12 medium (PAA) supplemented with 10% heat-inactivated FCS. VERO cells (EC ACC, 88020401), from kidney epithelial cells extracted from an African green monkey, adapted to grow on serum-free medium were maintained in serum-free Optipro medium (Invitrogen, Carlsbad, CA, USA). The cells were maintained in a humidified 5% CO 2 atmosphere at 37 1C.
IVR-116 wt, delNS1 50 and delNS1/IL-24 29 influenza viruses have been described previously. Heat inactivation of delNS1 virus was performed at 56 1C for 1 h. For propagation of the viruses VERO cells were infected at a multiplicity of infection (m.o.i.) of 0.1 and incubated in Optipro medium containing 5 mg/ml trypsin (Sigma-Aldrich, St. Louis, MO, USA) at 37 1C for 2 days. Virus concentrations were determined by plaque assay on VERO cells.
For stimulation experiments, cells were treated for 24 h with recombinant human IL-24 (100 ng/ml) (R&D Systems, Minneapolis, MN, USA), Z-Val-Ala-DL-Asp-fluoromethylketone (z-VAD fmk) (Bachem, Torrance, CA, USA), Necrostatin-1 (Nec-1) (Sigma-Aldrich) and Resveratrol (Sigma-Aldrich). The LPS used was ion-exchange chromatography-purified Escherichia coli LPS 055:B5 from Sigma-Aldrich (St. Louis), CL-097 and poly(I:C) from InvivoGen (San Diego, CA, USA). For stimulation experiments, tumor necrosis factor a (TNFa) (R&D Systems, Minneapolis, MN, USA), human interferon a (IFNa) (Health Protection Agency, London, UK) and human interferon gamma (IFNg) (Imukin, BoehringerIngelheim, Vienna, Austria) were used in concentrations of 50 and 100 ng/ml supernatant, respectively. For inhibition experiments, TNF activity was blocked by adding human TNFRII/TNFRSF1B/Fc chimera (20 mg/ml) (R&D Systems). For blocking of IFNa/b function, a combination of polyclonal rabbit anti-IFNa (5000 neutralizing U/ml) and rabbit anti-IFNb (2000 neutralizing U/ml) antibodies together with 20 mg/ml of a mouse anti-human IFNa/b receptor chain 2 mAb were used (all from PBL, New Brunswick, NJ, USA). For blocking of IFNg, mouse anti-human IFNg Ab (20 mg/ml) (R&D) was used.
Cytokine detection after infection with influenza viruses. Cells were infected with viruses and cultured for 24 h in medium containing 10% FCS. The supernatant was screened for human IL-24 by hIL-24 DuoSet ELISA (R&D Systems) according to the manufacturer's instructions.
Cell death analysis using Annexin V/propidium iodide double staining assay. Treated cells were collected after 24 h, washed with phosphate buffered saline (PBS) and stained with 5 ml fluorescein isothiocyanate (FITC)-conjugated Annexin V and PI for 15 min at room temperature in the dark (FITC Annexin V Apoptosis Detection Kit I, BD Pharmingen, Franklin Lakes, NJ, USA). The stained cells were then analyzed by a flow cytometer (Gallios Cytometer 1.1, Beckman Coulter, Brea, CA, USA). Co-immunoprecipitation of TLR3-bound complexes. For coimmunoprecipitation experiments, 1 Â 10 7 cells were infected and stimulated for 24 h, collected, washed in PBS and lysed in 1 ml lysis buffer (60 mM Tris/HCl pH6,8, 10% glycerol, 1%SDS, 5% b-mercaptoethanol). Lysates were immunoprecipitated overnight at 4 1C with 2mg of mouse anti-TLR3 antibodies (Santa Cruz) in the presence of 20 ml protein A/G Plus-AgaroseImmunoprecipitation Reagent (Santa Cruz). Agarose beads were recovered by centrifugation, washed extensively with cold lysis buffer and eluted with SDS loading buffer at 37 1C for 30min.
Small interfering RNA (siRNA) experiments. Cells were plated in six-well plates at 4 Â 10 4 cells. After overnight adherence, 100 ml serum-and antibiotic-free DMEM/F12 medium were mixed with 3 mg/ml linear polyethyleneimin (Polysciences Europe GmbH, Eppelheim, Germany) and 100 nM siRNA for 10 min at room temperature. Medium on the cells was changed to 900 ml fresh DMEM/F12 medium (supplemented with FCS) and the previously mixed RNA solution was added to each well. Cells were incubated overnight and cultured for 72 h in complete medium before treatment with viruses. TLR3 siRNA and caspase-8 siRNA were purchased from Santa Cruz Biotechnology; scrambled siRNA was from Qiagen (Germantown, MD, USA).
Tumor spheroid cultures. Tumor spheres were prepared as previously described. 51 In brief, cells were detached with EDTA (Life Technologies, Carlsbad, CA, USA), washed with PBS and placed in serum-free medium mixed with 20 ng/ ml epidermal growth factor (EGF PHG0311L, Life Technologies), 20 ng/ml basic fibroblast growth factor (bFGF PHG0021, Life Technologies) and 0.4% bovine serum albumin (BSA, Sigma-Aldrich) at a density of 1 Â 10 3 cells/ml and cultured in ultra-low attachment plates (CLS3473 Costar, Sigma-Aldrich). The sphere culture medium was changed every 48 h until the majority of spheres reached 300-400 mm in diameter.
Microscopy. Spheroid cultures were photographed on a Zeiss Axiovert 40 CFL microscope (Zeiss, Jena, Germany). For each condition, four different fields were captured and representative images were selected. All images were digitally processed for presentation with Adobe Photoshop CS4 (San Jose, CA, USA).
Statistical analysis. All data are represented by the mean and S.E.M. of at least three independent experiments. Statistical analysis was performed using the statistical software SPSS Statistics 17.0.0 (SPSS Software, Armonk, NY, USA) and with GraphPad Prism Version 5 (GraphPad Software, La Jolla, CA, USA). A probability of Po0.05 was considered statistically significant.
